Brain circuits in panic disorder (Q40831240)

24 September 2017

1 reference

title

Brain circuits in panic disorder (English)

1 reference

24 September 2017

Coplan JD

1

1 reference

PubMed ID

9861469

24 September 2017

Lydiard RB

series ordinal

2

1 reference

PubMed ID

9861469

24 September 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

24 September 2017

Biological Psychiatry

1 reference

24 September 2017

44

1 reference

24 September 2017

12

1 reference

24 September 2017

1264-1276

1 reference

Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Retrograde transport of D-[3H]-aspartate injected into the monkey amygdaloid complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Differential distribution of corticotropin-releasing hormone immunoreactive axons in monoaminergic nuclei of the human brainstem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Neurobiology of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

The cholecystokinin hypothesis of anxiety and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Cerebrovascular nerve fibers immunoreactive for tryptophan-5-hydroxylase in the rat: distribution, putative origin and comparison with sympathetic noradrenergic nerves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Plasma cortisol concentrations preceding lactate-induced panic. Psychological, biochemical, and physiological correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Advances in brain metabolism research: toward a moving picture of neural activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

5-HT and mechanisms of defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Cerebrospinal fluid levels of monoamine metabolites in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

A neuroanatomical hypothesis for panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

The neuroanatomy of 5-HT dysregulation and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

The effect of anxiety on cortical cerebral blood flow and metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

5-Hydroxytryptamine pathways in anxiety and its treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

The neurobiology of anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

CSF corticotropin-releasing factor is not affected in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Enhanced cerebrovascular responsiveness to hypercapnia following depletion of central serotonergic terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Panic attacks induced by doxapram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Recent developments in the psychopharmacology of anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Changes in Peripheral Benzodiazepine Receptors in Patients with Panic Disorder and Obsessive-Compulsive Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Inhibitory effect of GABA on cerebrovascular sympathetic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Panic attacks. A neurochemical overview of models and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Tricyclic antidepressants: Effects on the firing rate of brain noradrenergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Carbon dioxide hypersensitivity, hyperventilation, and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Effects of corticotropin-releasing factor on brain serotonergic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Neuroanatomical correlates of a lactate-induced anxiety attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Reduced benzodiazepine sensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Evidence of altered cerebral blood-flow relationships in acute phobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Yohimbine alters regional cerebral blood flow in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900300-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(98)00300-X

1 reference

24 September 2017

1 reference

PubMed ID

9861469